Wire · opportunities
Bracco, Avicenna.AI get FDA clearance for brain aneurysm AI software
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 13 November 2026 · Fusion42 review
Bracco and Avicenna.AI have received FDA 510(k) clearance for Uptunity Aneurysm, an AI software designed to detect and assess brain aneurysms on cerebral CT angiography images, providing quantitative follow-up measurements. Avicenna.AI will lead the product's promotion and commercial distribution in the U.S.
This Wire brief sits within Fusion42's coverage of Medtech, and 4 sources have reported it.
◆ ◆ The Wire takeaway
Medtech founders working on diagnostic AI now face a clearer path to US market entry with FDA clearance demonstrated for brain aneurysm detection. You need to prepare for faster adoption cycles and direct competition in radiology imaging tools.
◆ Coverage
4 sources · 13 Nov 2026
◆ Related on Wire
◆ Topics